We strive to create value for our investors by investing in novel and affordable healthcare solutions. Within this context our focus is entirely on operating profitably in an international environment. ViroGates follows an active investment strategy by looking for ‘intelligent’ capital.  Our investors follow our activities closely and the majority have active roles in the company.

From conception, our customers have always been at the heart of the ViroGates strategy and we strive to deepen our relationships to maximize success, growth and profitability. This includes recognizing what is needed to help people lead longer, better lives and using this knowledge effectively and swiftly. An example is our constant search for ways in which patients in resource-poor settings can access our products easily.


Our current investors include:

  1. The Way Forward ApS
  2. BioVision A/S
  3. 3AM A/S
  4. Missionpharma A/S
  5. Due Mila AB
  6. Medico Care ApS
  7. JEO Holding ApS
  8. IFU - The Industrialisation Fund for Developing Countries
  9. Numerous Private Business Angels

If you are interested to know more about ViroGates and investing, please contact our CEO, Betina Macho, at bm@ViroGates.com.

Read more about our corporate partners...